XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
TCRX TScan Therapeutics
- 2.050
- +0.010+0.49%
Close Feb 14 16:00 ET
- 2.050
- 0.0000.00%
Post 20:01 ET
115.84MMarket Cap-2.16P/E (TTM)
2.150High2.030Low263.72KVolume2.030Open2.040Pre Close544.75KTurnover0.75%Turnover RatioLossP/E (Static)56.51MShares9.69052wk High0.51P/B72.60MFloat Cap2.02052wk Low--Dividend TTM35.42MShs Float14.710Historical High--Div YieldTTM5.88%Amplitude1.450Historical Low2.065Avg Price1Lot Size
About TScan Therapeutics Company
TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge, Lea Hachigian, and Tomasz Kula in 2018 and is headquartered in Boston, MA.
Company Profile
SymbolTCRX
Company NameTScan Therapeutics
Listing DateJul 16, 2021
Issue Price15.00
Founded2018
CEODr. Gavin MacBeath, PhD
MarketNASDAQ
Employees154
Fiscal Year Ends12-31
Address830 Winter Street
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-857-399-9500
Websitehttp://www.tscan.com
Company Executives
- Name
- Position
- Salary
- Dr. Gavin MacBeath, PhD
- Chief Executive Officer and Director
- 3.20M
- Jason A. Amello
- Treasurer, Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Zoran Zdraveski
- Chief Legal and Strategy Officer and Secretary
- 1.58M
- Dr. Chrystal U. Louis, M.D.
- Chief Medical Officer
- --
- Leiden Dworak
- Vice President, Finance
- --
- Dr. Stephen R. Biggar,M.D.,PhD
- Chairman of the Board
- 123.17K
- Garry A. Nicholson
- Independent Director
- --
- Dr. Barbara Klencke, M.D.
- Independent Director
- 121.74K
- Dr. Gabriela Gruia, M.D.
- Independent Director
- 113.53K
- Katina Dorton, J.D.,M.B.A.
- Independent Director
- 132.59K
- Robert Keith Woods
- Independent Director
- 90.90K
Trending Stocks
Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Popular on moomoo
Feb 13 17:34
China's asset revaluation sparks debate: What are mooers buying?